Seminars in Liver Disease, volume 40, issue 02, pages 124-130

A Review on the Update of Combined Hepatocellular Cholangiocarcinoma

KOMUTA Mina 1
Yeh Matthew M 2, 3
2
 
Department of Pathology, University of Washington School of Medicine, Seattle
3
 
Department of Medicine, University of Washington School of Medicine, Seattle
Publication typeJournal Article
Publication date2019-12-30
Quartile SCImago
Q1
Quartile WOS
Q2
Impact factor4.2
ISSN02728087, 10988971
Hepatology
Abstract

Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a primary liver tumor with neoplastic components of both hepatocytic and cholangiocytic differentiation. This unique neoplasm is gaining increasing recognition due to the intriguing pathology, tumor biology, and clinical behavior. It also poses challenges in diagnosis, treatment, and research, largely because of its histological and phenotypic diversity that lead to confusion in terminology and classification. There have been efforts attempting to unify the terminology of this neoplasm recently. Advances in investigation in various aspects have also been made. This review aims to update the terminology, classification, and clinical and pathological characteristics of cHCC-CCA.

Citations by journals

1
2
Journal of Oncology
Journal of Oncology, 2, 10.53%
Journal of Oncology
2 publications, 10.53%
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, 1, 5.26%
Journal of Cancer Research and Clinical Oncology
1 publication, 5.26%
AJSP Review and Reports
AJSP Review and Reports, 1, 5.26%
AJSP Review and Reports
1 publication, 5.26%
World Journal of Hepatology
World Journal of Hepatology, 1, 5.26%
World Journal of Hepatology
1 publication, 5.26%
Vaccines
Vaccines, 1, 5.26%
Vaccines
1 publication, 5.26%
Cancers
Cancers, 1, 5.26%
Cancers
1 publication, 5.26%
Biomedicines
Biomedicines, 1, 5.26%
Biomedicines
1 publication, 5.26%
Human Pathology
Human Pathology, 1, 5.26%
Human Pathology
1 publication, 5.26%
Clinics in Liver Disease
Clinics in Liver Disease, 1, 5.26%
Clinics in Liver Disease
1 publication, 5.26%
Histopathology
Histopathology, 1, 5.26%
Histopathology
1 publication, 5.26%
Cancer Medicine
Cancer Medicine, 1, 5.26%
Cancer Medicine
1 publication, 5.26%
Clinical and molecular hepatology, 1, 5.26%
Clinical and molecular hepatology
1 publication, 5.26%
Surgical Pathology Clinics
Surgical Pathology Clinics, 1, 5.26%
Surgical Pathology Clinics
1 publication, 5.26%
Annals of Translational Medicine
Annals of Translational Medicine, 1, 5.26%
Annals of Translational Medicine
1 publication, 5.26%
Radiologia Medica
Radiologia Medica, 1, 5.26%
Radiologia Medica
1 publication, 5.26%
Abdominal Radiology
Abdominal Radiology, 1, 5.26%
Abdominal Radiology
1 publication, 5.26%
1
2

Citations by publishers

1
2
3
Springer Nature
Springer Nature, 3, 15.79%
Springer Nature
3 publications, 15.79%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 3, 15.79%
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 15.79%
Elsevier
Elsevier, 3, 15.79%
Elsevier
3 publications, 15.79%
Wiley
Wiley, 2, 10.53%
Wiley
2 publications, 10.53%
Hindawi Limited
Hindawi Limited, 2, 10.53%
Hindawi Limited
2 publications, 10.53%
Wolters Kluwer Health
Wolters Kluwer Health, 1, 5.26%
Wolters Kluwer Health
1 publication, 5.26%
Baishideng Publishing Group
Baishideng Publishing Group, 1, 5.26%
Baishideng Publishing Group
1 publication, 5.26%
Korean Association for the Study of the Liver, 1, 5.26%
Korean Association for the Study of the Liver
1 publication, 5.26%
AME Publishing Company
AME Publishing Company, 1, 5.26%
AME Publishing Company
1 publication, 5.26%
1
2
3
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
KOMUTA M., Yeh M. M. A Review on the Update of Combined Hepatocellular Cholangiocarcinoma // Seminars in Liver Disease. 2019. Vol. 40. No. 02. pp. 124-130.
GOST all authors (up to 50) Copy
KOMUTA M., Yeh M. M. A Review on the Update of Combined Hepatocellular Cholangiocarcinoma // Seminars in Liver Disease. 2019. Vol. 40. No. 02. pp. 124-130.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1055/s-0039-3402515
UR - https://doi.org/10.1055%2Fs-0039-3402515
TI - A Review on the Update of Combined Hepatocellular Cholangiocarcinoma
T2 - Seminars in Liver Disease
AU - KOMUTA, Mina
AU - Yeh, Matthew M
PY - 2019
DA - 2019/12/30 00:00:00
PB - Thieme
SP - 124-130
IS - 02
VL - 40
SN - 0272-8087
SN - 1098-8971
ER -
BibTex |
Cite this
BibTex Copy
@article{2019_KOMUTA,
author = {Mina KOMUTA and Matthew M Yeh},
title = {A Review on the Update of Combined Hepatocellular Cholangiocarcinoma},
journal = {Seminars in Liver Disease},
year = {2019},
volume = {40},
publisher = {Thieme},
month = {dec},
url = {https://doi.org/10.1055%2Fs-0039-3402515},
number = {02},
pages = {124--130},
doi = {10.1055/s-0039-3402515}
}
MLA
Cite this
MLA Copy
KOMUTA, Mina, et al. “A Review on the Update of Combined Hepatocellular Cholangiocarcinoma.” Seminars in Liver Disease, vol. 40, no. 02, Dec. 2019, pp. 124-130. https://doi.org/10.1055%2Fs-0039-3402515.
Found error?